ストックスクリーナーアプリを入手
2.00
0.76%
0.015
Standard Biotools Inc (LAB) 最新ニュース
Standard BioTools Inc. (NASDAQ:LAB) Position Decreased by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World
Standard BioTools Inc. (NASDAQ:LAB) Shares Purchased by Barclays PLC - MarketBeat
Standard BioTools to Present at the 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times
Standard BioTools CEO to Present at J.P. Morgan Healthcare Conference 2024 - StockTitan
Standard BioTools (NASDAQ:LAB) Trading Down 6.8%Here's What Happened - MarketBeat
BNP Paribas Financial Markets Lowers Stock Position in Standard BioTools Inc. (NASDAQ:LAB) - Defense World
After Leaping 35% Standard BioTools Inc. (NASDAQ:LAB) Shares Are Not Flying Under The Radar - Simply Wall St
Standard BioTools (NASDAQ:LAB) Shares Up 9.9%Still a Buy? - MarketBeat
What Are You Thinking About Investing In Standard BioTools Inc (NASDAQ: LAB) Stock? - Stocks Register
Standard BioTools Inc. (NASDAQ:LAB) Shares Purchased by Charles Schwab Investment Management Inc. - MarketBeat
Standard BioTools (STU:FLB) Enterprise Value : €386.4 Mil (As of Nov. 30, 2024) - GuruFocus.com
LAB Stock Price and Chart — NASDAQ:LAB - TradingView
Standard BioTools Inc. (NASDAQ:LAB) Short Interest Down 24.9% in November - MarketBeat
Standard BioTools (NASDAQ:LAB) Shares Gap UpShould You Buy? - MarketBeat
Standard BioTools (NASDAQ:LAB) adds US$78m to market cap in the past 7 days, though investors from three years ago are still down 59% - Simply Wall St
Sumitomo Mitsui Trust Group Inc. Decreases Holdings in Standard BioTools Inc. (NASDAQ:LAB) - MarketBeat
Indaba Capital Management L.P. Acquires New Stake in Standard Bi - GuruFocus.com
Creative Planning Purchases Shares of 20,328 Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Standard BioTools names new CFO By Investing.com - Investing.com Australia
ARK Investment Management LLC Lowers Stock Holdings in Standard BioTools Inc. (NASDAQ:LAB) - MarketBeat
Standard BioTools (STU:FLB) Price-to-Operating-Cash-Flow : (As of Nov. 07, 2024) - GuruFocus.com
Standard BioTools (STU:FLB) Revenue per Share : €0.67 (TTM As of Sep. 2024) - GuruFocus.com
Standard BioTools appoints Kim as Chief Financial Officer - TipRanks
Standard BioTools names new CFO - Investing.com
Standard BioTools Names Alex Kim as New CFO - TipRanks
Standard BioTools Appoints Alex Kim as Chief Financial Officer - GlobeNewswire
Standard BioTools Names Co-Founder Alex Kim as CFO, Brings 30-Year Industry Expertise | LAB Stock News - StockTitan
Form 10-Q STANDARD BIOTOOLS INC. For: Sep 30 - StreetInsider.com
Vanguard Group Inc's Strategic Acquisition in Standard BioTools Inc - GuruFocus.com
Earnings Release: Here's Why Analysts Cut Their Standard BioTools Inc. (NASDAQ:LAB) Price Target To US$3.17 - Yahoo Finance
TD Cowen trims Standard BioTools target, sees upside in margins and SomaScan performance - Investing.com Australia
Standard BioTools Q3 2024 Earnings Preview - MSN
Standard BioTools Third Quarter 2024 Earnings: Beats Expectations - Simply Wall St
Earnings call: Standard BioTools faces mixed Q3 results amid market challenges - Investing.com Australia
Standard BioTools Inc (LAB) Q3 2024 Earnings Call Highlights: Navigating Market Challenges with ... - Yahoo Finance
Standard BioTools Inc (LAB) Q3 2024 Earnings Call Highlights: Navigating Market Challenges with ... By GuruFocus - Investing.com Canada
Standard BioTools Inc. (NASDAQ:LAB) Q3 2024 Earnings Call Transcript - Insider Monkey
Standard BioTools price target lowered to $2.50 from $2.75 at TD Cowen - TipRanks
Standard BioTools to Participate in Upcoming Investor Conferences - The Manila Times
Standard Biotools earnings beat by $0.02, revenue topped estimates - Investing.com Canada
Standard BioTools Inc. Reports Q3 2024 Financial Performance - TipRanks
Standard BioTools: Q3 Earnings Snapshot - mySA
Standard BioTools reports Q3 EPS (7c), consensus (9c) - TipRanks
Standard BioTools (LAB) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
Standard BioTools Reports Strong Q3 2024 Performance - TipRanks
Standard BioTools, SomaLogic fall after shareholder nod for merger - MSN
Standard BioTools Reports Third Quarter 2024 Financial Results - The Manila Times
Standard BioTools Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Standard BioTools (NASDAQ:LAB) Trading 5.9% HigherShould You Buy? - MarketBeat
Standard BioTools And 2 Other Penny Stocks Executives Are Buying - MSN
Standard BioTools (NASDAQ:LAB) Has Debt But No Earnings; Should You Worry? - Simply Wall St
1.54%
大文字化:
|
ボリューム (24 時間):